Christopher R. Palma, M.D., Sc.M.

Locations

395 West Street, Suite 007
Canandaigua, NY 14424

400 Red Creek Drive, Suite 240
Rochester, NY 14623

About Me

Dr. Christopher Palma is an assistant professor of medicine in the division of Allergy Immunology and Rheumatology. As a rheumatologist he specializes in treating autoimmune diseases such as rheumatoid arthritis, systemic lupus, systemic vasculitis, sarcoidosis. He trained in microbiology and immuno...

Dr. Christopher Palma is an assistant professor of medicine in the division of Allergy Immunology and Rheumatology. As a rheumatologist he specializes in treating autoimmune diseases such as rheumatoid arthritis, systemic lupus, systemic vasculitis, sarcoidosis. He trained in microbiology and immunology at Johns Hopkins before coming to the University of Rochester NY to complete his medical training. Clinical practice locations include Rochester NY and Canandaigua NY. Research interests include the interaction of infections and autoimmune disease, immunocompetence, vasculitis, sarcoidosis and systemic lupus.

Professional Background

Dr. Christopher Palma studied at Yale University where he received a BS in Biology. Thesis work involved the study of evolution of virulence genes in human trypanosomes. He then attended graduate school at the Bloomberg School of Public Health at Johns Hopkins University obtaining as Masters of Scie...

Dr. Christopher Palma studied at Yale University where he received a BS in Biology. Thesis work involved the study of evolution of virulence genes in human trypanosomes. He then attended graduate school at the Bloomberg School of Public Health at Johns Hopkins University obtaining as Masters of Science degree in Molecular Immunology and Microbiology. Thesis work involved the study and generation of novel malaria vaccines utilizing live replication competent adenovirus. After graduate school he attended medical school at the University of Rochester where we he was awarded the George H. Whipple award. He completed internal medicine training and specialty training in Rheumatology at the University of Rochester's Strong Memorial Hospital. Currently Dr. Palma is an Assistant Professor in the department of medicine's division of Allergy Immunology and Rheumatology.

Faculty Appointments

Associate Professor - Department of Medicine, Allergy/Immunology and Rheumatology (SMD)

Credentials

Residency & Fellowship

Fellowship, Fellow, University of Rochester Medical Center. 2014 - 2016

Residency, Resident, University of Rochester Medical Center. 2012 - 2014

Internship, Internal Medicine, University of Rochester Medical Center. 2011 - 2012

Education

MD | University of Rochester. Internal Medicine. 2011

Awards

George H. Whipple Award.

Tettleman Travel Scholarship.

Research

Dr. Christopher Palma is an assistant professor of medicine in the division of Allergy Immunology and Rheumatology. Research interests include the interactions of infections and autoimmune diseases, viral diseases, immunocompetence.

Clinical Trials

A Phase 1/2, Open-label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Systemic Lupus Erythematosus

Lead Researcher: Christopher R Palma

Systemic lupus erythematosus (SLE) is a disease where the immune system attacks healthy tissue. SLE can be unpredictable, flaring up and calming down over time. In some cases, it can damage organs like the kidneys, leading to a serious complicatio...

Publications

Journal Articles

Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.

O'Halloran JA, Ko ER, Anstrom KJ, Kedar E, McCarthy MW, Panettieri RA, Maillo M, Nunez PS, Lachiewicz AM, Gonzalez C, Smith PB, de Tai SM, Khan A, Lora AJM, Salathe M, Capo G, Gonzalez DR, Patterson TF, Palma C, Ariza H, Lima MP, Blamoun J, Nannini EC, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Witting B, Wang JP, Parra-Rodriguez L, Der T, Willsey K, Wen J, Silverstein A, O'Brien SM, Al-Khalidi HR, Maldonado MA, Melsheimer R, Ferguson WG, McNulty SE, Zakroysky P, Halabi S, Benjamin DK, Butler S, Atkinson JC, Adam SJ, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG,

JAMA.. 2023 July 10 Epub 07/10/2023.

Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome.

Rein L, Calero K, Shah R, Ojielo C, Hudock KM, Lodhi S, Sadaka F, Bellam S, Palma C, Hager DN, Daniel J, Schaub R, O'Hayer K, Theodoropoulos NM

Critical care medicine.. 2022 October 13 Epub 10/13/2022.

Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

O'Halloran J, Kedar E, Anstrom KJ, McCarthy MW, Ko ER, Segura Nunez P, Boucher C, Smith PB, Panettieri RA, Mendivil Tuchia de Tai S, Maillo M, Khan A, Mena Lora AJ, Salathe M, Capo G, Rodriguez Gonzalez D, Patterson TF, Palma C, Ariza H, Patelli Lima M, Lachiewicz AM, Blamoun J, Nannini E, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Wittig B, Benjamin DK, McNulty SE, Zakroysky P, Halabi S, Butler S, Atkinson J, Adam SJ, Melsheimer R, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG

medRxiv : the preprint server for health sciences.. 2022 September 26 Epub 09/26/2022.

Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.

Ko ER, Anstrom KJ, Panettieri RA, Lachiewicz AM, Maillo M, O'Halloran JA, Boucher C, Smith PB, McCarthy MW, Segura Nunez P, Mendivil Tuchia de Tai S, Khan A, Mena Lora AJ, Salathe M, Kedar E, Capo G, Rodríguez Gonzalez D, Patterson TF, Palma C, Ariza H, Patelli Lima M, Blamoun J, Nannini EC, Sprinz E, Mykietiuk A, Wang JP, Parra-Rodriguez L, Der T, Willsey K, Benjamin DK, Wen J, Zakroysky P, Halabi S, Silverstein A, McNulty SE, O'Brien SM, Al-Khalidi HR, Butler S, Atkinson J, Adam SJ, Chang S, Maldonado MA, Proscham M, LaVange L, Bozzette SA, Powderly WG,

medRxiv : the preprint server for health sciences.. 2022 September 26 Epub 09/26/2022.

Risk factors for the development of cardiovascular events within one year from the diagnosis of giant cell arteritis.

Ocon AJ, Palma C

Clinical and experimental rheumatology.. 2021 June 25 Epub 06/25/2021.

SARS CoV-2 infection among patients using immunomodulatory therapies.

Winthrop KL, Brunton AE, Beekmann S, Polgreen P, Baddley J, Saag KG, Calabrese C, Calabrese L, Robinson PC, Wallace ZS, Curtis JR,

Annals of the rheumatic diseases.. 2020 August 5 Epub 08/05/2020.

Fibrosis, Thrombosis, and Dacrocytosis: An Unusual Case of Male Systemic Lupus Erythematosus.

Wu MQ, Preslar M, Katerji H, Palma C, Cameron SJ

The American journal of medicine.. 2019 December 20 Epub 12/20/2019.

Adenovirus particles that display the Plasmodium falciparum circumsporozoite protein NANP repeat induce sporozoite-neutralizing antibodies in mice.

Palma C, Overstreet MG, Guedon JM, Hoiczyk E, Ward C, Karen KA, Zavala F, Ketner G

Vaccine.. 2011 February 1129 (8):1683-9. Epub 01/01/2011.

Characterization of di-, tri-, and tetranucleotide microsatellite markers with perfect repeats for Trypanosoma brucei and related species.

Balmer O, Palma C, Macleod A, Caccone A

Molecular ecology notes.. 2006 June 6 (2):508-510. Epub 1900 01 01.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.